Cardiac Senescence Biomarkers
Pronunciation: suh-NESS-uhns
Laboratory markers that indicate cellular aging processes specifically within cardiovascular tissue.
Full Definition
Cardiac senescence biomarkers are specific laboratory measurements that reflect the biological aging processes occurring within cardiovascular tissues, including markers of cellular senescence, inflammatory aging, and oxidative stress. These biomarkers may include elevated levels of senescence-associated proteins, inflammatory cytokines, and DNA damage markers that correlate with cardiovascular aging rather than acute disease processes. In geriatric cardiology, these markers help distinguish between normal aging-related changes and pathological processes, guide prognosis, and potentially identify patients who might benefit from senolytic or anti-aging interventions. The interpretation of these biomarkers requires understanding of age-appropriate reference ranges.
Usage
Usage note: Capitalize when referring to specific standardized panels; lowercase for general concept.
In Context
- "Elevated cardiac senescence biomarkers suggested accelerated cardiovascular aging despite the patient's relatively young chronological age." — Laboratory interpretation note
- "Serial measurement of cardiac senescence biomarkers will help monitor the effectiveness of the anti-aging intervention." — Clinical trial protocol